Publicaciones en las que colabora con Carmen Gómez Guerrero (11)

2024

  1. Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2020

  1. Lipotoxicity and diabetic nephropathy: Novel mechanistic insights and therapeutic opportunities

    International Journal of Molecular Sciences, Vol. 21, Núm. 7

  2. Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy

    International Journal of Molecular Sciences, Vol. 21, Núm. 11

2019

  1. Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction

    Molecular Oncology, Vol. 13, Núm. 9, pp. 1887-1897

  2. Molecular evidence of field cancerization initiated by diabetes in colon cancer patients

    Molecular Oncology, Vol. 13, Núm. 4, pp. 857-872

2018

  1. Targeting inflammation in diabetic nephropathy: a tale of hope

    Expert Opinion on Investigational Drugs, Vol. 27, Núm. 11, pp. 917-930

2017

  1. 2017 update on the relationship between diabetes and colorectal cancer: Epidemiology, potential molecular mechanisms and therapeutic implications

    Oncotarget, Vol. 8, Núm. 11, pp. 18456-18485

  2. Atrasentan for the treatment of diabetic nephropathy

    Expert Opinion on Investigational Drugs, Vol. 26, Núm. 6, pp. 741-750

  3. Colon cancer modulation by a diabetic environment: A single institutional experience

    PLoS ONE, Vol. 12, Núm. 3

2013

  1. Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice

    PLoS ONE, Vol. 8, Núm. 12

2011

  1. Animal models of cardiovascular diseases

    Journal of Biomedicine and Biotechnology, Vol. 2011